Outcome Resources Inc.

1-866-877-2053

Pharmacy Benefits Management

The Hospice Clinician Blog

4 article(s) matching tag "pediatric end of life care"  Clear Search

Subscribe to Blog:

Search:



ABH Gel  Acetaminophen  acetaminophen  acid suppression. ranitidine  aclidinium bromide  acute phosphate nephropathy  adverse drug events  Agitation  albuterol  aliskiren  allergy  alprazolam  Alzheimer's  Alzheimers  Ambien  Amitiza  and Methadone (Dolophine)  Angina  anorexia  antibiotics  anticoagulation  antiplatelet  antipsychotic  antipsychotics  appetite  Arcapta Neohaler  Aricept  arrhythmia  aspirin  asthma  Ativan  Avastin  Avinza  Azithromycin  azithromycin  Baclofen  barbiturates  Beers Criteria  Beers List  Benzodiazepines  benzodiazepines  bexarotene  bone metastases  bone pain  Boniva  bowel movement  breakthrough pain  Breo Ellipta  brochodilator  Buprenorphine  BuprenorphinePranay Parihar  cancer pain  Cardiac Arrhythmia  cardiovascular  Celexa  Chlorpromazine (Thorazine)  Choosing Wisely  Cimetidine  Citalopram  Citalopram (Celexa)  CMS  codeine  colace  Combivent  Combivent Respimat  compounded medication  constipation  controlled prescriptions  controlled substance  COPD  Coronary Artery Disease  corticosteroid  Coumadin  counterfeit drugs  dabigatran  Darvocet  Darvon  DEA  Delirium  dementia  depression  Diazepam  docusate  Doxepin  drug disposal  drug shortage  drug shortages  dry powder inhaler  dyspnea  Edluar  Endo  Endocet  Endodan  enema  escitalopram  Escitalopram (Lexapro)  eszopiclone  ethics  Exalgo  Exelon  famotidine  faxing prescriptions  FDA  FDA REMS  fentanyl  fentanyl sublingual spray  first-generation antihistamines  fleet enema  flu vaccine  Gastrointestinal  generic  generic Lexapro  generic Seroquel  generics  H2RA  haloperidol  Haloperidol (Haldol)  Heart  Heart Failure  hiccups  hospice  Hospice Action Network  hospice advocacy  hospice ceu  hospice clinical  hospice clinical support  hospice compliance  hospice Conditions of Participation  hospice constipation  hospice COP  hospice CoP compliance  hospice cough  hospice docusate  hospice drug  hospice drug choice  hospice drug disposal  hospice drug dosage  hospice drugs  hospice drugs,delirium,haloperidol,haldol,antipsychotics  hospice education  hospice education programs  hospice medication  hospice medication disposal  hospice medication orders  hospice medication review  hospice methadone  hospice opioid conversion  hospice opioids  hospice pain management  hospice patient  hospice patient care  hospice PBM  hospice pbm  hospice PBM choice  hospice pharmacist  hospice pharmacy  hospice pharmacy benefit manager  hospice pharmacy decision  hospice seizure  hospice symptom management  hospira carpuject  Hydrocodone  hydrocodone  hydrocodone/APAP  hydrocodone/APAP recall  hydromorphone  hydromorphone recall  hypoglycemics  IBS  incomplete cross-tolerance  influenza  inhaler  inhaler technique  INR  insomnia  Intermezzo  ipratropium  irritable bowel  Kadian  ketamine  kidney disease  laxative  Lazanda  leg cramps  leukotriene-receptor antagonist  Linaclotide  Lipitor  long acting opioids  Lorazepam  Lortab  lovastatin drug interactions  low dose aspirin  LTRA  Lubiprostone  Lunesta  lung cancer  medical marijuana  Medicare Part D  medication adherence  medication allergy  medication disposal  medication orders  medication review  medication shortage  medication tapering  Megace  Meningitis  meperidine  metered dose inhaler  Methadone  methadone dosage  Methylprednisolone  methyphenidate  Metoclopramide  Midazolam  morphine  morphine injection recall  morphine sulfate  multiple sclerosis  muscle relaxants  naproxen  narcotic  nausea  NHPCO  Nitrate  nitrofurantoin  Nitroglycerin  NSAID  OIG  olanzapine  ondansetron hydrochloride  Opana  Opana ER  opioid  opioid allergy  opioid disposal  opioid induced constipation  opioid-induced constipation  opioids  overactive bladder  Oxybutynin  Oxycodone  oxycodone  Oxycontin  oxycontin  oxymorphone  oxytrol  palliative care  Parkinson's  patient compliance  PBM decision  pediatric  pediatric end of life care  pediatric hospice  pediatric hospice care  pediatric palliative  pediatric palliative care  pediatric palliative symptom management  Pepcid  Percocet  Percodan  PPI  Pradaxa  Product Information  Propoxyphene  Prostate Cancer  Proton Pump Inhibitor  pruritis  QT interval  QT Prolongation  quetiapine  quinine  Recall  Reglan  Relistor  renal impairment  research  Revatio  Risperidone  risperidone  Roflumilast  Ropinirole  Salonpas  Sativex  Schedule II  schedule II medications  scheduled medications  Scopolamine  sennosides  Seroquel  Silenor  Singulair  Sonata  Spiriva  Sprix  START and STOPP  statins liver function  statins safety  statins side effects  stool softener  stroke  Sublingual Nitroglycerin  subsys  sulfa allergy  Tagamet  Targretin  targretin  TdP  tertiary TCAs  tiotropium  TIRF REMS Access Program  Transderm Scop  transmucosal immediate-release fentanyl  Tudorza Pressair  Tylenol  tylenol  Valium  Versed  Vicodin  vicodin  vitamin K  warfarin  writing orders  zaleplon  Zantac  zithromax  Zofran  zolpidem  Zolpimist  Zydone  Zyprexa 

08/21/2012

Reminder About the Risks of Using Codeine in Pediatric Palliative Care

The FDA is currently reviewing recent reports of children who developed serious adverse effects or died after taking codeine for post-surgical pain relief. Three children died and one child developed life-threatening respiratory depression after taking codeine. All four children used codeine for pain after having their tonsils and/or adenoids removed for treatment of obstructive sleep apnea. The children were given appropriate doses of codeine, but were found upon genetic testing to be “ultra-rapid metabolizers” of codeine, which resulted in overdose.

Codeine is not active as an analgesic until it is converted to morphine in the liver. The enzyme that converts codeine to morphine is called cytochrome P450 2D6 (CYP2D6). There is a wide genetic variation in the level of activity of CYP2D6. Some people have fairly inactive CYP2D6 enzymes, so they don’t get much pain relief from codeine (they are called “poor metabolizers”). Others, like the children described above, have extremely active CYP2D6 enzymes, so they may be prescribed an appropriate dose of codeine, but end up with much higher levels of morphine in their blood – and overdose can result. It is hypothesized that these particular children, with a history of sleep apnea, were already at a higher risk of fatal respiratory depression from opioids.

Ethnicity is a factor in CYP2D6 variability. In most populations, 1-7% of people are ultra-rapid metabolizers of codeine. But in Africans, as much as 29% of the population are ultra-rapid metabolizers. On the flip side, approximately 6-10% of Caucasians are poor metabolizers; the percentage is slightly higher in African-Americans and slightly lower in Asians.

The FDA is reviewing the safety reports about codeine, and looking at the use of codeine in other patients and other settings, and said it will provide a public update when the process is complete. In the meantime, healthcare professionals should be aware of the risks of using codeine in children, and should perhaps consider other drugs instead of codeine. If prescribing codeine-containing drugs, the lowest effective dose for the shortest period of time should be used on an as-needed basis (i.e., not scheduled around the clock). Parents and caregivers who observe unusual sleepiness, confusion, or difficult or noisy breathing in their child should seek medical attention immediately, as these are signs of overdose.

Photo Credit




08/14/2012

Pediatric Palliative Care: Strategies for Administering Medications

A huge challenge facing parents, caregivers and healthcare professionals who take care of ill children is getting those children to take their medicine. When children won’t take their medicine, optimal care is obviously challenged, whether in a chronically ill child who must take routine medicine to control their disease or in an acutely ill child who must take an as-needed medication to control symptoms. In this article, I’d like to present some strategies, which can be employed by anyone caring for an ill child, for getting kids to take medications.

Dealing with Bad Flavor

Medicines, especially liquids, are notorious for tasting bad. When flavor is an issue, try the following:

  • Use the cheek pocket. To avoid the tongue as much as possible, place the medicine between the cheek and lower jaw, toward the back of the mouth. From there, liquid medicine will glide straight down the throat, avoiding the taste buds.
  • Offer a “spoonful of sugar”. Combine the medicine with a little sweet-tasting food or drink to mask the bitterness, or offer a “chaser”. Always check with a pharmacist before mixing medicines with food or drink to make sure it is OK, and make sure the child is able to consume the entire food or drink so he or she gets the full dose.
  • Ask about FlavoRx. FlavoRx is an FDA-approved medication flavoring system available at many pharmacies, including all Walgreens, Rite-Aid, CVS, Target and Walmart pharmacies. The child’s medicine can be customized with one of 18 available flavors. They also offer “Pill Glide”, which is a flavored spray designed to make pills easier to swallow.
  • Rerigerate. Liquid meds are usually more palatable when served cold. Check with the pharmacist first.
  • Ask about alternatives. Sometimes another delivery device, formulation, route of administration or brand will be more acceptable to the child.
  • Try a pacifier medicine dispenser. This nifty device, which retails for about $5, includes a pacifier equipped with a medication dispensing reservoir inside. The medication is slowly dispensed as the infant or child sucks on the pacifier.

Strategies for Toddlers and Older Kids

Like most things with toddlers and older kids, medicine-taking can quickly become a turf war, resulting in a lot of stress and fighting. To avoid getting to that point, try these strategies:

  • Make medicine more enticing and fun. Add food coloring, decorate their medication cup, or have a medication “tea party.”
  • Create a routine and reward successes. Toddlers and young children thrive on routine. Create a routine surrounding medications and a designated spot in the house. Use the reward system to recognize each success.
  • Explain yourself. Explain how medicine helps kids get well, in terms they will understand, such as "This medicine will help you feel better so you can go back to the playground.“ or "You didn't wake up at all last night. That's because the medicine took your pain away."
  • Offer choices whenever you can. Taking medicine is not optional, but some aspects of taking medication can be. For example, ask a child “Would you like apple juice or orange juice with your medicine?” Giving them a choice in any aspect you can will help them feel that they have some control in the process.
  • Avoid physical struggles. Sometimes, you may have no choice, but try to avoid physical struggles at all costs. If medicine-taking is associated with a negative experience in the child’s mind, that will only make it that much more difficult the next time around.
  • Watch your own demeanor. Children reflect the attitude of the adults around them. So if you treat medicine-taking as a horrible thing, changes are the child will too.

With all children, anticipate and prevent side effects as much as possible. Children make strong and fast associations, so even one negative experience may create a difficult situation where the child no longer wants to take the medicine.

What strategies have you found useful in getting children to take their medicine?

Photo Credit




06/30/2011

Pediatric Palliative Care: Pediatric Acetaminophen Concentration & Dosing

Currently, pediatric acetaminophen is available in two liquid concentrations: 160 mg per 5 mL (usually labeled as “children’s”) and 160 mg per 1.6 mL (usually labeled as “infants’”, as it is given in drop form).  The availability of two concentrations has resulted in confusion and dosing errors, and has been a long-standing source of concern.

In May of this year, the Consumer Healthcare Products Association (CHPA) announced an industry-wide transition to a single pediatric acetaminophen concentration. Companies are voluntarily shifting to the 160 mg per 5 mL concentration. Eventually, the more concentrated infants’ drops will no longer be available. This shift is consistent with an FDA Advisory Committee recommendation made in 2009.

Pediatric acetaminophen dosing remains 10-15 mg/kg/dose.

Dosing chart for liquid pediatric acetaminophen products 

 Patient weight (lb)

Typical patient age (mo)

 Dose (mL) for older, more concentrated products (160 mg per 1.6 mL)

 Dose (mL) for uniform concentration products (160 mg per 5 mL)

 6-11

 0-3

 0.4

 1.25

 12-17

 4-11

 0.8

 2.5

 18-23

 12-23

 1.2

 3.75

 24-35

 24-36

 1.6

 5

Outcome Resources is a pharmacy partner exclusively for hospices with experienced pediatric palliative care pharmacists on staff and available for consultation to our hospice clients. If you are interested in learning more about how a partnership with Outcome Resources can benefit your hospice, including your pediatric palliative care program, Contact Us today.

"




07/22/2010

Pediatric Palliative Symptom Management

 

This final article in our pediatric series will focus on the management of some of the most common non-pain symptoms encountered in pediatric palliative care. Research is notoriously lacking in this area, so much of what is done in pediatric palliative care is derived from the general pediatric population, from adult palliative care, or simply from clinical experience.

Specific symptom complexes that are addressed include: anxiety & depression, agitation, insomnia, anorexia-cachexia, nausea-vomiting, constipation, and dyspnea. Specific medication strategies will be presented for managing each of these troubling symptoms in pediatric hospice patients. 

Pediatric Palliative Care

 

Download the complete copy of Part 3 of our Pediatric Palliative Care Series: Pediatric Palliative Symptom Management. This article includes common non-pain symptoms such as depression, agitation, and dyspnea.

 

 

 

 

"




First 10 <<Previous 10 Next 10 >> Last 10

 

 


Education Resources and Support for Hospices

Stay up-to-date on the latest hospice pharmacy benefits management information and tools with a variety of education resources and support at no extra charge. We offer presentations live at your facility, over the Internet or viaEducational Resources and Support for Hospicesteleconference, online service education programs, customized courses, and courses accredited for nursing continuing education credit.

See all of our educational resources>>

Clinical hospice and palliative cae consultation

Clinical Services

Our palliative care experts provide clinical consulting on important medication management and care decisions. Our non-dispensing pharmacists provide focused attention and unbiased advice.

 

Read more about our clinical pharmacy benefits management services>>

Why Use A PBM?

Contracting with multiple pharmacies, doing all the reporting, trying to stay current with medical practices and stay compliant while keeping costs down? There’s an easier and more effective way.

Find out how using a pharmacy benefits manager (PBM) can help you>>

Why Use a PBM